Loading…
Based on limited metadata with no full letter text available, RLC Labs Inc. received an FDA Warning Letter on October 9, 2020 regarding drug products. While the specific violations cannot be determined from the available information, the letter was issued under FDA's drug regulatory authority. To understand the particular compliance concerns and required corrective actions, the complete Warning Letter text would need to be reviewed.